Tag: approval

TORONTO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQX:IDKFF) a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce that it has closed its previously announced private placement financing (the “Private Placement”) pursuant to which it has issued an aggregate of 11,600,000 units (“Units”) of the Company in exchange for total gross proceeds of $696,000, or $0.06 per Unit.

WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today released a letter to stockholders.

WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “Company) (Nasdaq: TVGN), today announced that it expects to receive $1 million in grant funding to advance Tevogen.AI, its artificial intelligence–powered drug discovery and development program.

Leveraging the feasibility results from the NRCan-funded project, the project team is now aiming to complete the front-end engineering design for three facilities to convert wood waste feedstock into renewable diesel fuel

AB “Ignitis grupė” (hereinafter – the Group) informs that on the 1^st of August 2025 the Ministry of Finance of the Republic of Lithuania (hereinafter – the Ministry of Finance), which exercises the rights of the majority shareholder, announced the selection of three members from among civil servants to the Group’s Supervisory Board, in the areas of public policy and governance, regulatory, accounting and audit competences. Candidates may apply until the 21^st of August 2025 (inclusive).